Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2050
https://www.valueinhealthjournal.com/article/S1098-3015(15)04126-1/fulltext
Title :
Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04126-1&doi=10.1016/j.jval.2015.09.2050
First page :
A599
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1470